X
Exicure, Inc. Common StockXCUR
Exicure, Inc. (Nasdaq: XCUR) has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder.
US StocksHealthcareSmall CapBiotechnology
XCUR の価格トレンド
Exicure, Inc. Common Stock · TradingView フルチャート
NASDAQ:XCUR